Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Guy Hermans, Ph.D.

Chief Scientific Officer at Isogenica


Guy joined Isogenica as CSO in 2016, bringing in over a decade of experience in antibody fragment discovery and early development, as well as antibody discovery technology development. At Isogenica, he drives technology development programs and licensee interactions.
Prior to joining industry, he performed research into the pathogenesis and immunotherapy of autoimmune and inflammatory disorders, ranging from immunotherapy trials to target discovery and validation work at Stanford University Medical School.

Agenda Sessions